G Medical Innovations Holdings Ltd (NASDAQ:GMVD – Get Rating) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 257,600 shares, an increase of 205.6% from the August 31st total of 84,300 shares. Based on an average trading volume of 1,050,000 shares, the short-interest ratio is presently 0.2 days. Currently, 0.4% of the shares of the stock are sold short.
Institutional Trading of G Medical Innovations
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Regal Partners Ltd purchased a new stake in shares of G Medical Innovations during the second quarter worth about $322,000. Goldman Sachs Group Inc. purchased a new stake in shares of G Medical Innovations during the second quarter worth about $40,000. Virtu Financial LLC purchased a new stake in shares of G Medical Innovations during the first quarter worth about $35,000. Finally, Tradewinds Capital Management LLC increased its stake in shares of G Medical Innovations by 143.7% during the first quarter. Tradewinds Capital Management LLC now owns 48,730 shares of the company's stock worth $62,000 after purchasing an additional 28,730 shares in the last quarter.
Get
G Medical Innovations alerts:
G Medical Innovations Stock Performance
Shares of G Medical Innovations stock opened at $0.22 on Wednesday. The firm has a 50-day simple moving average of $0.35 and a two-hundred day simple moving average of $0.77. G Medical Innovations has a fifty-two week low of $0.21 and a fifty-two week high of $6.74.
About G Medical Innovations
(Get Rating)
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days.
See Also
- Get a free copy of the StockNews.com research report on G Medical Innovations (GMVD)
- Defensive Stocks For A Volatile Market
- SunPower Is Ready To Power Up Triple-Digit Earnings Gains
- Will UPS Be Next to Deliver a Warning?
- Is This the Darkest Before the Dawn for Gap Stock?
- Build A Better Tech Portfolio With Jabil Inc.
Receive News & Ratings for G Medical Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for G Medical Innovations and related companies with MarketBeat.com's FREE daily email newsletter.
G醫療創新控股有限公司(納斯達克:GMVD-GET評級)是9月份空頭股數大幅增長的目標。截至9月15日,空頭股數共有257,600股,比8月31日的84,300股增加了205.6%。以1050,000股的平均成交量計算,目前短息比率為0.2天。目前,該股0.4%的股份被賣空。
G醫療創新的制度性交易
一些機構投資者和對沖基金最近調整了對該股的持有量。富豪合夥公司在第二季度購買了G醫療創新公司的新股份,價值約32.2萬美元。高盛股份有限公司在第二季度購買了G醫療創新公司的新股,價值約40,000美元。Virtu Financial LLC在第一季度購買了G Medical Innovation的新股份,價值約3.5萬美元。最後,貿易風資本管理有限責任公司在第一季度增持了G醫療創新公司的股份143.7%。Tradewinds Capital Management LLC現在持有該公司48,730股股票,價值62,000美元,上個季度又購買了28,730股。
到達
G醫療創新警報:
G醫療創新類股業績
週三,G醫療創新公司的股票開盤報0.22美元。該公司的50日簡單移動均線切入位在0.35美元,200日簡單移動均線切入位在0.77美元。G醫療創新公司的股價為0.21美元,為52周低點,52周高點為6.74美元。
關於G醫療創新
(獲取評級)
G醫療創新控股有限公司及其子公司是一家處於早期商業階段的醫療保健公司,致力於在美國、中國和以色列開發下一代移動醫療和遠端醫療解決方案。該公司的產品包括Prizma,這是一種即插即用的醫療設備,具有電子病歷功能和臨床分級報告標準,可以測量生命體徵;以及擴展Holter Patch系統,這是一種患者佩戴的多通道生物感測器,可以連續捕獲長達14天的心電數據。
另請參閱
- 免費獲取StockNews.com關於G醫療創新的研究報告(GMVD)
- 防禦性股票應對動盪的市場
- SunPower準備推動三位數的收益增長
- UPS會成為下一個發出警告的公司嗎?
- 這是Gap Stock黎明前最黑暗的一次嗎?
- 與捷普公司一起打造更好的技術產品組合。
接受《G醫療創新日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對G醫療創新和相關公司的最新新聞和分析師評級的每日簡明摘要。